Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Aug 31, 2025 | (Q6)Feb 28, 2025 | (FY)Aug 31, 2024 | (Q6)Feb 29, 2024 | (FY)Aug 31, 2023 | (Q6)Feb 28, 2023 | (FY)Aug 31, 2022 | (Q6)Feb 28, 2022 | (FY)Aug 31, 2021 | (Q6)Feb 28, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 13.95%1.45B | 12.61%720.86M | 17.10%1.27B | 16.80%640.11M | 19.34%1.08B | 19.28%548.04M | 2.96%907.76M | 3.16%459.47M | 15.78%881.66M | 13.12%445.37M |
| Operating income | 13.95%1.45B | 12.61%720.86M | 17.10%1.27B | 16.80%640.11M | 19.34%1.08B | 19.28%548.04M | 2.96%907.76M | 3.16%459.47M | 15.78%881.66M | 13.12%445.37M |
| Cost of sales | -20.03%-722.82M | -23.32%-364.17M | -31.29%-602.21M | -31.15%-295.3M | -7.77%-458.7M | -7.39%-225.17M | -3.52%-425.61M | -1.79%-209.68M | -33.10%-411.14M | -22.81%-206M |
| Operating expenses | -20.03%-722.82M | -23.32%-364.17M | -31.29%-602.21M | -31.15%-295.3M | -7.77%-458.7M | -7.39%-225.17M | -3.52%-425.61M | -1.79%-209.68M | -33.10%-411.14M | -22.81%-206M |
| Gross profit | 8.45%722.62M | 3.45%356.69M | 6.68%666.32M | 6.79%344.81M | 29.55%624.6M | 29.26%322.88M | 2.47%482.15M | 4.35%249.79M | 3.96%470.51M | 5.93%239.37M |
| Selling expenses | -56.41%-45.69M | -32.97%-17.91M | -68.98%-29.21M | -114.00%-13.47M | 13.21%-17.29M | 33.92%-6.3M | 23.58%-19.92M | 52.31%-9.53M | -67.88%-26.07M | -70.81%-19.98M |
| Administrative expenses | -30.55%-181.89M | -39.38%-81.79M | 6.49%-139.33M | 10.74%-58.68M | -29.34%-149M | -14.24%-65.74M | -11.63%-115.2M | -22.79%-57.55M | -4.13%-103.2M | 19.67%-46.87M |
| Special items of operating profit | -7.41%70.26M | 97.04%29.38M | 101.29%75.88M | -13.75%14.91M | 1.86%37.69M | -3.29%17.29M | 131.68%37.01M | 476.79%17.88M | -814.55%-116.81M | -173.13%-4.74M |
| Operating profit | -1.46%565.29M | -0.42%286.37M | 15.65%573.65M | 7.25%287.57M | 29.16%496.02M | 33.67%268.13M | 71.11%384.04M | 19.55%200.59M | -36.65%224.44M | 3.30%167.79M |
| Financing income | -72.74%1.03M | -53.77%1.29M | -33.98%3.76M | -23.34%2.79M | -5.77%5.7M | 17.63%3.64M | -30.74%6.05M | -44.99%3.09M | 4.84%8.74M | 41.12%5.62M |
| Financing cost | 21.55%-70.46M | 20.34%-39.66M | 13.22%-89.82M | 4.62%-49.78M | 6.88%-103.5M | -9.46%-52.19M | -74.91%-111.14M | -116.59%-47.68M | -22.93%-63.54M | 17.33%-22.02M |
| Earning before tax | 1.69%495.86M | 3.09%248M | 22.44%487.6M | 9.56%240.57M | 42.76%398.22M | 40.75%219.57M | 64.44%278.94M | 3.04%156M | -45.44%169.63M | 8.31%151.39M |
| Tax | -2.90%-37.57M | 33.78%-13.68M | -605.47%-36.51M | -357.65%-20.66M | 72.99%-5.18M | 65.46%-4.52M | 26.79%-19.16M | -10.67%-13.07M | -513.65%-26.17M | -612.73%-11.81M |
| After-tax profit from continuing operations | 1.60%458.29M | 6.55%234.31M | 14.77%451.09M | 2.26%219.91M | 51.30%393.05M | 50.46%215.06M | 81.09%259.78M | 2.40%142.93M | -53.22%143.46M | 1.06%139.58M |
| Earning after tax | 1.60%458.29M | 6.55%234.31M | 14.77%451.09M | 2.26%219.91M | 51.30%393.05M | 50.46%215.06M | 81.09%259.78M | 2.40%142.93M | -53.22%143.46M | 1.06%139.58M |
| Profit attributable to shareholders | 1.60%458.29M | 6.55%234.31M | 14.77%451.09M | 2.26%219.91M | 51.30%393.05M | 50.46%215.06M | 81.09%259.78M | 2.40%142.93M | -53.22%143.46M | 1.06%139.58M |
| Basic earnings per share | 1.60%0.382 | 6.56%0.195 | 14.63%0.376 | 2.23%0.183 | 51.85%0.328 | 49.17%0.179 | 80.00%0.216 | 3.45%0.12 | -55.56%0.12 | -10.77%0.116 |
| Diluted earnings per share | 1.60%0.382 | 6.56%0.195 | 14.63%0.376 | 2.23%0.183 | 51.85%0.328 | 49.17%0.179 | 80.00%0.216 | 3.45%0.12 | -55.56%0.12 | -10.77%0.116 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.